1. Home
  2. MGN vs NEPH Comparison

MGN vs NEPH Comparison

Compare MGN & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGN

Megan Holdings Limited Ordinary Shares

N/A

Current Price

$0.17

Market Cap

33.6M

Sector

N/A

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$2.98

Market Cap

31.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MGN
NEPH
Founded
2020
1997
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.6M
31.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
MGN
NEPH
Price
$0.17
$2.98
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
4.5M
47.4K
Earning Date
04-30-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.11
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
$32.33
$25.68
Revenue Growth
N/A
32.67
52 Week Low
$0.13
$1.78
52 Week High
$5.18
$6.42

Technical Indicators

Market Signals
Indicator
MGN
NEPH
Relative Strength Index (RSI) 29.91 35.55
Support Level N/A $2.85
Resistance Level $2.25 $4.26
Average True Range (ATR) 0.44 0.20
MACD -0.49 -0.01
Stochastic Oscillator 0.94 13.26

Price Performance

Historical Comparison
MGN
NEPH

About MGN Megan Holdings Limited Ordinary Shares

Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: